Approval · Notice of Compliance 23711 · 2020
ENABLEX: Notice of Compliance 23711
Issued May 29, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23711
- Date
- May 29, 2020
- Company
- Searchlight Pharma Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of alternate drug product manufacturing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ENABLEX | Not yet assigned | — |
Medicinal ingredients
- DARIFENACIN HYDROBROMIDE 7.5 MG per TAB
- DARIFENACIN HYDROBROMIDE 15 MG per TAB